Cypress Asset Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-4,645
| Closed | -$362K | – | 106 |
|
|
2024
Q3 | $362K | Buy |
4,645
+1,520
| +49% | +$118K | 0.09% | 91 |
|
|
2024
Q2 | $253K | Buy |
+3,125
| New | +$253K | 0.07% | 95 |
|
|
2021
Q1 | – | Sell |
-4,250
| Closed | -$212K | – | 139 |
|
|
2020
Q4 | $212K | Hold |
4,250
| – | – | 0.06% | 141 |
|
|
2020
Q3 | $233K | Hold |
4,250
| – | – | 0.07% | 125 |
|
|
2020
Q2 | $225K | Buy |
+4,250
| New | +$225K | 0.08% | 123 |
|
|
2018
Q1 | – | Sell |
-6,175
| Closed | -$214K | – | 177 |
|
|
2017
Q4 | $214K | Sell |
6,175
-450
| -7% | -$15.6K | 0.05% | 178 |
|
|
2017
Q3 | $224K | Hold |
6,625
| – | – | 0.05% | 184 |
|
|
2017
Q2 | $226K | Sell |
6,625
-4,450
| -40% | -$152K | 0.05% | 183 |
|
|
2017
Q1 | $345K | Sell |
11,075
-3,100
| -22% | -$96.6K | 0.07% | 169 |
|
|
2016
Q4 | $387K | Sell |
14,175
-1,050
| -7% | -$28.7K | 0.07% | 159 |
|
|
2016
Q3 | $500K | Sell |
15,225
-3,645
| -19% | -$120K | 0.1% | 137 |
|
|
2016
Q2 | $570K | Sell |
18,870
-102,525
| -84% | -$3.1M | 0.11% | 137 |
|
|
2016
Q1 | $3.42M | Sell |
121,395
-2,275
| -2% | -$64.1K | 0.69% | 50 |
|
|
2015
Q4 | $4.2M | Sell |
123,670
-1,330
| -1% | -$45.2K | 0.84% | 38 |
|
|
2015
Q3 | $3.98M | Buy |
125,000
+190
| +0.2% | +$6.05K | 0.84% | 45 |
|
|
2015
Q2 | $3.98M | Buy |
124,810
+2,190
| +2% | +$69.8K | 0.75% | 46 |
|
|
2015
Q1 | $4.2M | Buy |
+122,620
| New | +$4.2M | 0.78% | 43 |
|